IL157216A0 - Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same - Google Patents
Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL157216A0 IL157216A0 IL15721602A IL15721602A IL157216A0 IL 157216 A0 IL157216 A0 IL 157216A0 IL 15721602 A IL15721602 A IL 15721602A IL 15721602 A IL15721602 A IL 15721602A IL 157216 A0 IL157216 A0 IL 157216A0
- Authority
- IL
- Israel
- Prior art keywords
- crystalline forms
- same
- pharmaceutical compositions
- pyrimidine nucleoside
- compositions containing
- Prior art date
Links
- 150000003833 nucleoside derivatives Chemical class 0.000 title abstract 2
- 239000002718 pyrimidine nucleoside Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001033128 | 2001-02-09 | ||
| PCT/JP2002/000986 WO2002064609A1 (fr) | 2001-02-09 | 2002-02-06 | Cristaux de derive de nucleoside de pyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157216A0 true IL157216A0 (en) | 2004-02-19 |
Family
ID=18896929
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15721602A IL157216A0 (en) | 2001-02-09 | 2002-02-06 | Crystalline forms of pyrimidine nucleoside derivatives and pharmaceutical compositions containing the same |
| IL157216A IL157216A (en) | 2001-02-09 | 2003-08-04 | Crystalline forms of nucleoside pyrimidine history and pharmaceutical preparations containing them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL157216A IL157216A (en) | 2001-02-09 | 2003-08-04 | Crystalline forms of nucleoside pyrimidine history and pharmaceutical preparations containing them |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1364959B1 (cs) |
| JP (2) | JP3748536B2 (cs) |
| KR (1) | KR100679904B1 (cs) |
| CN (1) | CN100408591C (cs) |
| AT (1) | ATE361929T1 (cs) |
| AU (1) | AU2002230164B2 (cs) |
| BR (2) | BRPI0207102A8 (cs) |
| CA (1) | CA2437994C (cs) |
| CY (1) | CY1106685T1 (cs) |
| CZ (1) | CZ303241B6 (cs) |
| DE (1) | DE60220024T2 (cs) |
| DK (1) | DK1364959T3 (cs) |
| ES (1) | ES2286237T3 (cs) |
| HU (1) | HU229294B1 (cs) |
| IL (2) | IL157216A0 (cs) |
| MX (1) | MXPA03007123A (cs) |
| NZ (1) | NZ527393A (cs) |
| PT (1) | PT1364959E (cs) |
| RU (1) | RU2256666C2 (cs) |
| WO (1) | WO2002064609A1 (cs) |
| ZA (1) | ZA200306121B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070101408A (ko) | 1999-09-02 | 2007-10-16 | 이비덴 가부시키가이샤 | 프린트배선판 및 프린트배선판의 제조방법 |
| KR20100018626A (ko) | 1999-09-02 | 2010-02-17 | 이비덴 가부시키가이샤 | 프린트배선판 및 그 제조방법 |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| PL2307002T3 (pl) | 2008-06-09 | 2013-05-31 | Cyclacel Ltd | Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina |
| WO2012140436A1 (en) | 2011-04-14 | 2012-10-18 | Cyclacel Limited | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| KR102081042B1 (ko) * | 2012-03-15 | 2020-02-26 | 셀젠 카르 엘엘씨 | 상피 성장 인자 수용체 키나제 억제제의 고체 형태 |
| AU2016229319B2 (en) | 2015-03-09 | 2020-05-07 | W.R. Grace & Co.-Conn. | Crystalline form of nicotinamide riboside |
| WO2019126482A1 (en) | 2017-12-22 | 2019-06-27 | Elysium Health, Inc. | Crystalline forms of nicotinamide riboside chloride |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| CA2079413C (en) * | 1991-09-30 | 2003-09-09 | Masakatsu Kaneko | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja active IP Right Grant
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2018C008I2 (cs) | ||
| IL144461A0 (en) | Quinoline and quinazoline derivatives and pharmaceutical compositions containing them | |
| IL135536A0 (en) | Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same | |
| IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
| DK1442024T3 (da) | Aminobenzamidderivater som glycogensystasekinase 3 beta-inhibitorer | |
| HK1053831A1 (zh) | 作为治疗药物的激酶抑制剂 | |
| ES2175624T3 (es) | Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen. | |
| GR3030167T3 (en) | Amidino derivatives useful as nitric oxide synthase inhibitors | |
| IS8825A (is) | Ný kristölluð og myndlaus form af tríasól (4,5-D) pýrimídínefnasambandi | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| YU57603A (sh) | Inhibitori fosfodiesteraze 4 | |
| CY1106685T1 (el) | Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη | |
| PT1448853E (pt) | Melhoramentos relacionados com branqueadores ópticos | |
| MXPA02004440A (es) | Derivados de pirrol como inhibidores de la fosfodiesterasa vii. | |
| IL136100A0 (en) | Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same | |
| CA2452036A1 (en) | 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity | |
| GB0215392D0 (en) | Chemical compounds | |
| WO2002062798A3 (en) | Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose | |
| MY129094A (en) | Condensed polycyclic compounds | |
| DE69827614D1 (de) | Chinoxalindionen | |
| WO2003086412A3 (fr) | Derives poly-phosphonates pour compositions dentifrices | |
| IL166313A0 (en) | Indoline derivatives and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |